Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
42.9M
-
Shares change
-
-5.58M
-
Total reported value, excl. options
-
$68.6M
-
Value change
-
-$9.32M
-
Put/Call ratio
-
7.48
-
Number of buys
-
31
-
Number of sells
-
-59
-
Price
-
$1.60
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q2 2021
115 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q2 2021.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.9M shares
of 237M outstanding shares and own 18.11% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (16.6M shares), Nuveen Asset Management, LLC (5.9M shares), VANGUARD GROUP INC (5.61M shares), BlackRock Inc. (2.18M shares), GEODE CAPITAL MANAGEMENT, LLC (1.05M shares), MILLENNIUM MANAGEMENT LLC (1M shares), Clearline Capital LP (923K shares), GSA CAPITAL PARTNERS LLP (861K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (648K shares), and Magnetar Financial LLC (606K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.